Table S5 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Year: 2024
Type: other
Abstract: Growth inhibitory concentrations (GI50) of NBI-961, doxorubicin and vincristine.
Authors: Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth, Syed Hassan Mehdi, Baku Acharya, Debasmita Saha, Kevin Naceanceno, Stephanie D. Byrum, Aaron J. Storey, Ying-Zhi Xu, Claire Doshier, Vijay Patel, Ginell R. Post, Annick De Loose, Analiz Rodriguez, Leonard D. Shultz, Fenghuang Zhan, Donghoon Yoon, Brendan Frett, Samantha Kendrick
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4392383687